Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled

Campbell, I. A.; Douglas, J. G.; Francis, R. M.; Prescott, R. J.; Reid, D. M.
September 2004
Thorax;Sep2004, Vol. 59 Issue 9, p761
Academic Journal
The article presents a five year study to ascertain whether cyclical etidronate and/or calcium can act as prevention and treatment for osteoporosis and fractures in patients with asthma, receiving oral and/or inhaled glucocorticoid treatment. The study, conducted by the Research Committee of the British Thoracic Society, was done on 352 patients of asthma receiving the glucocorticoid treatment for at least 1 year. The analysis used the property of the factorial design whereby, in the absence of interaction between etidronate and calcium, all patients contribute to the evaluation of each factor.


Related Articles

  • Prevalence of osteoporosis risk factors and need to bone mineral density testing in patients with pathologic fractures: Kashani hospital,Esfahan. Siadat, Zahra Dana; Rahmani, Siamak; Mahmoudian, Seyed Ahmad; Eshaghi, Seyed Reza // Journal of Isfahan Medical School;1/16/2012, Vol. 29 Issue 163, p1 

    Background: Pathologic fracture is a very serious complication of osteoporosis,we don't have any effective treatment for osteoporosis so determination of risk factors for osteoporosis and pathologic fracture and subsequently prevention of the disease is attended. The goal of this study was to...

  • Phone reviews for asthma get clinical backing.  // Pulse;5/7/2008, Vol. 68 Issue 16, p2 

    The article reports on the clinical guidelines of the British Thoracic Society and Scottish Intercollegiate Guidelines Network which support the telephone reviews for asthma. The guidelines claim that the reviews are appropriate for patients who are unwilling to attend regular appointments. They...

  • Symptoms concern highlighted by new asthma guideline.  // Practice Nurse;5/23/2008, Vol. 35 Issue 10, p8 

    The article reports that many people with asthma are enduring an unacceptably high level of symptoms, according to a new guideline published by the British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN). The General Practice Airways Group (GPIAG), which helped to...

  • Education: Journals Club - Combination inhalers for asthma - Curriculum statement 15.8.  // GP: General Practitioner;9/17/2010, p43 

    The article offers miscellaneous information related to the field of medicine. It is reported that, according to a medical study, combined use of salmeterol and fluticasone propionate reduces the number of exacerbations in patients with mild to moderate asthma, compared to their individual use....

  • Pseudogout attack induced during etidronate disodium therapy. Watanabe, Hiroshi; Yamada, Sayaka; Anayama, Satoshi; Sato, Ei-ichi; Maekawa, Shingo; Sugiyama, Hajime; Nakajima, Ikumasa // Modern Rheumatology (Springer Science & Business Media B.V.);Jun2006, Vol. 16 Issue 2, p117 

    We report the first case of pseudogout attack in the distal interphalangeal (DIP) joints during etidronate disodium therapy. A 64-year-old woman had intermittent administration of etidronate disodium (Didronel; Sumitomo, Osaka, Japan) alone because of osteoporosis. Each cycle consisted of a...

  • Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. Suzuki, Yasuo; Nawata, Hajime; Soen, Satoshi; Fujiwara, Saeko; Nakayama, Hisanori; Tanaka, Ikuko; Ozono, Keiichi; Sagawa, Akira; Takayanagi, Ryoichi; Tanaka, Hiroyuki; Miki, Takami; Masunari, Naomi; Tanaka, Yoshiya // Journal of Bone & Mineral Metabolism;Jul2014, Vol. 32 Issue 4, p337 

    In this article, the author discusses treatment and management of glucocorticoid (GC) induced osteoporosis which is widely used to treat various inflammatory and immunologic that cause rheumatic, respiratory, and skin diseases. Topics discussed include cohort analysis on Japanese patients with...

  • Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment.  // ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p44 

    The article cites a study which states that etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment. The study was published in the 2004 issue of the journal "Thorax." The study included 352 men and women 50 to 70 years of age who...

  • Glucocorticoid-induced osteoporosis. Sutcliffe, Anne // Practice Nurse;5/12/2006, Vol. 31 Issue 9, p62 

    The article presents information on glucocorticoid-induced osteoporosis. Glucocorticoid steroids can have a dramatic effect on bone mass. Lifestyle changes and treatments can reduce the risk of fracture. Osteoporosis is a skeletal disease characterized by low bone mass and microarchitectural...

  • Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study. Ringe, J. D.; Dorst, A.; Faber, H.; Kipshoven, C.; Rovati, L. C.; Setnikar, I. // Rheumatology International;May2005, Vol. 25 Issue 4, p296 

    In a three-year pilot study on 52 women with severe postmenopausal osteoporosis, treatment with etidronate followed by calcium and vitamin D (ECaD) was compared to etidronate followed by monofluorophosphate, calcium and vitamin D (EFCaD). BMD in lumbar spine, total hip and femoral neck increased...


Read the Article


Sign out of this library

Other Topics